Renal Denervation

This channel includes news and new technology innovations for renal denervation used to treat hypertension. Renal denervation is a catheter-based therapy. The catheter is into the renal artery and delivers radio-frequency energy to ablate the nerves in the vessel wall that regulate vasoconstriction. This leaves the vessel permanently in the widest open position to allow greater blood flow to the kidneys. This enables greater filtration of the blood and removal of excess water that causes hypertension

News

June 6, 2013 — Boston Scientific Corporation reported interim data from the REDUCE-HTN clinical program, which ...

Home June 06, 2013
Home
News

June 3, 2013 — St. Jude Medical Inc. announced that the company’s EnligHTN multi-electrode renal denervation system ...

Home June 03, 2013
Home
News

May 30, 2013 — Kona Medical announced three and six month results from the WAVE I study, a first-in-man study evaluating ...

Home May 30, 2013
Home
News

May 17, 2013 — Can high blood pressure be safely reduced and controlled by “disconnecting” nerves in the kidneys? That ...

Home May 17, 2013
Home
News

April 24, 2013 — Cardiosonic Inc. announced the completion of the first phase of patient enrollment in its first-in-man ...

Home April 24, 2013
Home
Feature

April 1, 2013 — Rox Medical announced enrollment of the first U.K. patients in the CONTROL-HTN international randomized ...

Home April 01, 2013
Home
Symplicity Renal Denervation System Medtronic Inc. Parallel Review Program
Feature

March 12, 2013 — Medtronic Inc. announced the U.S. Food and Drug Administration (FDA) and the Centers for Medicare and ...

Home March 12, 2013
Home
Renal Denervation Clinical Study EnligHTNment Trial St. Jude Medical
Feature

March 1, 2013 — St. Jude Medical Inc. announced plans for a new landmark clinical study that will evaluate whether renal ...

Home March 01, 2013
Home
St. Jude Medical EnligHTN II trial Renal Denervation System
Feature

February 13, 2013 — St. Jude Medical Inc. announced enrollment of the first patient in the EnligHTN II trial. This post ...

Home February 13, 2013
Home
Feature | Dave Fornell

My job as editor of DAIC is to help readers keep tabs on the latest in cardiovascular technology and trends. With ...

Home February 04, 2013
Home
Blog

My job as editor of DAIC is to help readers keep tabs on the latest in cardiovascular technology and trends. With ...

Home February 04, 2013
Home
Top stories of 2012 in cardiology
Feature | Dave Fornell

To help identify trends and find out what DAIC readers are interested in, the magazine takes note of what they click on ...

Home January 29, 2013
Home
Feature

January 16, 2013 — Covidien began the commercial launch of the OneShot Renal Denervation System, an over the wire ...

Home January 16, 2013
Home
2012 Top 10 Advances in Heart Disease and Stroke Research
Feature

December 28, 2012 — Resuscitation, cell regeneration, a new high blood pressure treatment and developments in devices ...

Home December 28, 2012
Home
News

December 27, 2012 — Cardiosonic Inc., a private developer of technology in the field of renal denervation for the ...

Home December 27, 2012
Home
Subscribe Now